🇺🇸 FDA
Patent

US 7056734

Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof

granted A61KA61K35/39A61K38/00

Quick answer

US patent 7056734 (Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services, N.I.H. expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services, N.I.H.
Grant date
Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K35/39, A61K38/00, A61K38/26, A61P